Development of gummi drugs of aripiprazole as hospital formulations.


About half of patients with schizophrenia have poor adherence to taking medication, so many have recurrence, therefore, providing formulations that enable patients to continue their medication without interruption is important. We aimed to develop a gummi drug that contains aripiprazole (which can reduce schizophrenia and manic symptoms in bipolar disorder… (More)
DOI: 10.1248/cpb.c15-00038


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics